Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology Diagnostics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel FAK-targeting compounds and F-18 radiolabels. Efficient synthesis routes for tumor diagnosis and therapy intermediates.